PA Research Foundation
Support the Duck Stop Cancer is the PA Research Foundation's signature FUNdraising campaign for Cancer Research. The Foundation funds world class research into deadly and debilitating disease at the home of the world's first cancer vaccine.
The PA Campus is one of the most energetic research precincts in the nation. With up to 1300 researchers calling the PA Hospital home, together these researchers will investigate disease prevention, early detection, treatments and cures.
Cancer affects 1 in every 3 Australian women and 1 in every 2 Australian men.
Unfortunately cancer touches the lives of all of us either directly or through the ones we know and love. But the good news is, cancer is no longer a death sentence.
Thanks to medical research over the past decades, many cancers are now treatable, and diagnostic tools available to prevent otherwise deadly cancers, so many patients can now live long and healthy lives.
However there is still a long way to go on our mission to stop cancer - but, together with your support we can continue to raise funds for our dedicated medical research teams.
Research Teams with a track record of excellence in medical outcomes, Research Teams who bought us the world's first cancer vaccine, Research Teams who have saved millions of lives around the world and Research teams that with your support will deliver to the world the next great cancer breakthrough.
Current funded cancer research projects and studies at the PA Campus:
- Testing whether a virus infection on the skin contributes to the risk of developing skin cancer and seeing if the ability to mount an immune response can contribute to the risk of developing skin cancer.
- Investigating the treatment for surgically inoperable Stage II and III melanoma.
- Testing the effectiveness of chemotherapy dose on different body sizes of women with breast cancer and if there is an increased rate of mortality.
- Clinical trials into developing a better treatment for ER- breast cancer, one of the most aggressive types of breast cancer. Identifying molecules that can be used as an indicator for prostate cancer with the aim to develop personalised effective cancer treatments and improved clinical diagnosis and treatment monitoring.
- Applying the understanding of the genetic make-up and hormonal composition to develop innovative drugs and therapies to treat and cure prostate cancer.
- Understanding the function and structure of genomes in cutaneous squamous cell carcinoma of the head and neck where the cancer has spread to surrounding nerves.